Amylin Watches Its R & D; Costs Continue to Rise

Amylin Watches Its R & D; Costs Continue to Rise
Neurogenetics Secures $10M In Series B Preferred Stock

BIOTECH
by Marion Webb, Senior Staff Writer

Amylin Pharmaceuticals, Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

• 52 weekly issues
• Subscriber-only digital content every business day, plus full access to SDBJ.com archives
• Book of Lists — the most comprehensive business resource in San Diego
• San Diego 500 — influential business leaders you need to know

Yours for only $99

First name:

Last name:

Email:

Address:

Zip:

CC Number:

Cvv:

Exp Month:

Exp Year: